No Data
No Data
Individual investor, Yuken Teigensuke: Successfully navigate the autumn market by thoroughly focusing on performance! Targeting 6 stocks for short-term price fluctuations in the near future. [FISCO Social Reporter]
The following is a comment written by individual investor Mr. Yugen-Tei Tamisuke, a FISCO social reporter (Blog: Profitable Stock Information "Nekodan's Stocks Knows No Limits"). At FISCO, we strive to actively collaborate with individuals who actively share information in order to deliver a wider range of information to investors. ----------- *After the congratulatory market before the election on October 21, 2024 at 11:00, what will happen to the market after the election? What will happen to stock prices based on the election results.
Stocks that moved the previous day part 1: JINSHD, Bic Camera, TOWA, etc.
Stock Name <Code> Closing Price on the 15th ⇒ Previous Day Comparison. Kintetsu Department Stores <8244> 2110 +105 Operating profit for the previous period increased by 31.7%, and dividend estimates were raised. PR TIMES <3922> 1576 -92 Operating profit for the previous period increased by 7.6%, a decrease in profit growth rate from the 41.0% increase in the first quarter. Landnet <2991> 1670 +1001 split shares in a 2:1 ratio. Immune Biologics <4570> 505 +80 Obtained a patent in Japan for 'anti-HIV antibodies and method for manufacturing the same.' Shikaku <70>
Active and newly established stocks in the afternoon session.
*Kintetsu Department Store <8244> 2110 +105 The operating profit for the previous period increased by 31.7%, and the dividend forecast was revised upward. * PR TIMES <3922> 1576 -92 The operating profit for the previous period increased by 7.6%, a decrease in profit growth rate from the 41.0% increase in the first quarter. * Rando Net <2991> 1670 +1001 Split stocks into 2 shares. * Immuno-Biologicals <4570> 505 +80 Obtained a patent in Japan for 'antibodies against HIV and their production methods.' * Shikaku <7049> 664 +492
October 15th [Today's Investment Strategy]
[Fisco Selected Stock] [Material Stock] Cosmos Pharmaceuticals <3349> 7320 yen (10/11) A drugstore based in Kyushu. They announced their first quarter results. Operating profit increased by 28.8% year-on-year to 11.5 billion yen. Despite a temporary decline in profitability due to in-house competition, they carried out new store openings and expanded their store network to new business territories without hesitation. The operating profit for the fiscal year ending in May 2025 is expected to be 31.6 billion yen, a 0.3% increase from the previous period. The progress rate for the first quarter compared to the full-year forecast is 36.6%. The full-year forecast is for a slight increase in profit.
Steady, supported by high U.S. stock prices, but the upside is a heavy development.
[Emerging markets individual stock strategy] Today's emerging markets are expected to show a strong performance. In the U.S. stock market on the 11th of last weekend's 3-day weekend in Tokyo, the Dow Jones Industrial Average rose by 409.74 points (+0.97%). The market was supported by the positive earnings of banks and expectations for major corporate earnings. Also, the Producer Price Index (PPI) did not significantly change the trajectory of interest rate cuts for the remainder of the year, providing a sense of reassurance. Yesterday, the market continued to rise, with an increase of $201.36, reaching 43,065.22 dollars (+0.47%).
Ryohin Keikaku, operating profit up by 69.4% to 56.1 billion yen on August 24, financial estimates for August 25 showing a 2.0% decrease to 55 billion yen.
Ryohin Keikaku <7453> announced its financial results for the August 2024 period, with operating revenue increasing by 13.8% year-on-year to 661.677 million yen, and operating profit increasing by 69.4% to 56.135 million yen. Both operating revenue and each stage profit reached record highs. The improvement in operating gross profit margin was due to the effects of domestic price adjustments and the suppression of price reductions. For the August 2025 period, operating revenue increased by 10.9% year-on-year to 734 billion yen, while operating profit decreased by 2% to 55 billion yen.
No Data
No Data